Insulin Aspart-Szjj

Insulin Aspart-Szjj is indicated for the treatment of diabetes mellitus in adults and children (age 2 and older) requiring insulin for glycemic control. It is specifically designed to manage postprandial (after-meal) blood glucose levels and is commonly used as part of a comprehensive diabetes management plan that may include longer-acting insulins, oral medications, diet, and exercise.

As a rapid-acting insulin analog, Insulin Aspart-Szjj works by binding to insulin receptors on cells throughout the body, promoting cellular uptake of glucose from the bloodstream. It facilitates the conversion of glucose into energy and helps store excess glucose in the liver and muscles. Its rapid onset of action allows it to more closely mimic the body's natural insulin response to food intake compared to regular human insulin.

Insulin Aspart-Szjj should be administered subcutaneously and must never be given intravenously or used in insulin pumps. Patients should monitor blood glucose regularly and rotate injection sites to prevent lipodystrophy. Hypoglycemia is the most common adverse effect, and patients should be educated on recognition and treatment of low blood sugar. Dosage is individualized based on metabolic needs, blood glucose monitoring results, and dietary intake. This medication should be used with caution in patients with renal or hepatic impairment.